{"id":"https://openalex.org/W4367296438","doi":"https://doi.org/10.1212/wnl.0000000000203830","title":"Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients (P12-3.005)","display_name":"Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients (P12-3.005)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367296438","doi":"https://doi.org/10.1212/wnl.0000000000203830"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000203830","doi":"https://doi.org/10.1212/wnl.0000000000203830","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203830","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075712759","display_name":"Frederik Novak","orcid":"https://orcid.org/0000-0003-3402-4759","observed_orcids":["https://orcid.org/0000-0003-3402-4759"]},"institutions":[{"id":"https://openalex.org/I4210134581","display_name":"Hospital South West Jutland","ror":"https://ror.org/03pzgk858","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210134581"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Frederik Novak","raw_affiliation_strings":["Neurology, Southwest Jutland Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Southwest Jutland Hospital","institution_ids":["https://openalex.org/I4210134581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066313657","display_name":"Hamza Bajwa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134581","display_name":"Hospital South West Jutland","ror":"https://ror.org/03pzgk858","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210134581"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Hamza Bajwa","raw_affiliation_strings":["Neurology, Southwest Jutland Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Southwest Jutland Hospital","institution_ids":["https://openalex.org/I4210134581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011512441","display_name":"John Eugenio Coia","orcid":"https://orcid.org/0000-0002-4966-8453","observed_orcids":["https://orcid.org/0000-0002-4966-8453"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"John Eugenio Coia","raw_affiliation_strings":["Regional Health Research, University of Southern Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Health Research, University of Southern Denmark","institution_ids":["https://openalex.org/I177969490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012599968","display_name":"Anna Christine Nilsson","orcid":"https://orcid.org/0000-0001-7885-8400","observed_orcids":["https://orcid.org/0000-0001-7885-8400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Christine Nilsson","raw_affiliation_strings":["Clinical Immunology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041923825","display_name":"Christian Nielsen","orcid":"https://orcid.org/0000-0002-5711-6595","observed_orcids":["https://orcid.org/0000-0002-5711-6595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Nielsen","raw_affiliation_strings":["Clinical Immunology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054391046","display_name":"Dorte Kinggaard Holm","orcid":"https://orcid.org/0000-0002-8156-7177","observed_orcids":["https://orcid.org/0000-0002-8156-7177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dorte Holm","raw_affiliation_strings":["Clinical Immunology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007509586","display_name":"Kamilla \u00d8stergaard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100334","display_name":"Nordsj\u00e6llands Hospital","ror":"https://ror.org/016nge880","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I4210100334"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Kamilla \u00d8stergaard","raw_affiliation_strings":["Neurology, Nordsj\u00e6llands Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Nordsj\u00e6llands Hospital","institution_ids":["https://openalex.org/I4210100334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071253490","display_name":"Mathilde Vilhelmine Miller Hvidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162587","display_name":"Regional Hospital Central Jutland","ror":"https://ror.org/056brkm80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210162587"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mathilde Hvidt","raw_affiliation_strings":["Neurology, Hospitalsenhed Midt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Hospitalsenhed Midt","institution_ids":["https://openalex.org/I4210162587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022322491","display_name":"Keld\u2010Erik Byg","orcid":"https://orcid.org/0000-0003-4834-5457","observed_orcids":["https://orcid.org/0000-0003-4834-5457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keld-Erik Byg","raw_affiliation_strings":["Rheumatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028156447","display_name":"I\u015f\u0131k Somuncu Johansen","orcid":"https://orcid.org/0000-0002-2189-9823","observed_orcids":["https://orcid.org/0000-0002-2189-9823"]},"institutions":[{"id":"https://openalex.org/I2801498763","display_name":"Odense University Hospital","ror":"https://ror.org/00ey0ed83","country_code":"DK","type":"funder","lineage":["https://openalex.org/I2801498763"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Isik Johansen","raw_affiliation_strings":["Infectious Diseases, Odense University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Odense University Hospital","institution_ids":["https://openalex.org/I2801498763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074133788","display_name":"Kristen Mittl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen Mittl","raw_affiliation_strings":["Neurology, UCSF"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, UCSF","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038938348","display_name":"William M. Rowles","orcid":"https://orcid.org/0000-0002-5613-0483","observed_orcids":["https://orcid.org/0000-0002-5613-0483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Rowles","raw_affiliation_strings":["Neurology, UCSF"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, UCSF","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028232512","display_name":"Scott S. Zamvil","orcid":"https://orcid.org/0000-0003-2720-9915","observed_orcids":["https://orcid.org/0000-0003-2720-9915"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Zamvil","raw_affiliation_strings":["Neurology, University of CA, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, University of CA, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051842646","display_name":"Riley M. Bove","orcid":"https://orcid.org/0000-0002-2034-8800","observed_orcids":["https://orcid.org/0000-0002-2034-8800"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riley Bove","raw_affiliation_strings":["Neurology, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030531337","display_name":"Joseph J. Sabatino","orcid":"https://orcid.org/0000-0002-6804-7441","observed_orcids":["https://orcid.org/0000-0002-6804-7441"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Sabatino","raw_affiliation_strings":["Neurology, University of California San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, University of California San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066965222","display_name":"Tobias Sejb\u00e6k","orcid":"https://orcid.org/0000-0002-7682-2188","observed_orcids":["https://orcid.org/0000-0002-7682-2188"]},"institutions":[{"id":"https://openalex.org/I4210134581","display_name":"Hospital South West Jutland","ror":"https://ror.org/03pzgk858","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210134581"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Tobias Sejbaek","raw_affiliation_strings":["Neurology, Southwest Jutland Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Southwest Jutland Hospital","institution_ids":["https://openalex.org/I4210134581"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0651422,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.75},{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":1.0},{"id":"https://openalex.org/keywords/bnt162b2-mrna-vaccine","display_name":"BNT162b2 mRNA vaccine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/humoral-immune-response","display_name":"humoral immune response","score":0.972000002861023},{"id":"https://openalex.org/keywords/antibody-levels","display_name":"antibody levels","score":0.7120000123977661},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.8510000109672546},{"id":"https://openalex.org/keywords/covid-19-vaccination","display_name":"COVID-19 vaccination","score":0.656000018119812},{"id":"https://openalex.org/keywords/cd4-and-cd8-t-cells","display_name":"CD4 and CD8 T cells","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8638907670974731},{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.8407413959503174},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6708317399024963},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.628746509552002},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6184260249137878},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5076578855514526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48312804102897644},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47578275203704834},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4483446478843689},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000203830","doi":"https://doi.org/10.1212/wnl.0000000000203830","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203830","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4366982129","https://openalex.org/W3169673565","https://openalex.org/W4402285155","https://openalex.org/W4210573808","https://openalex.org/W4409965173","https://openalex.org/W4283378317","https://openalex.org/W4214924490","https://openalex.org/W4229022607","https://openalex.org/W4389375395","https://openalex.org/W4312176561"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"investigate":[2],"the":[3,43,50,59,101,152,164,167,177,196,215,225,270,294,328,355,446,465,484,509,528,547,566,584,608,632,657,682,706,731,755,829,851,873,900],"rate":[4],"of":[5,15,45,62,72,140,205,218,233,255,296,320,330,347,357,369,448,467,486,511,530,549,568,586,610,634,659,684,708,733,757,774,785,797,831,853,875,902,917],"breakthrough":[6,136,234,263],"SARS-CoV-2":[7,148,210,243],"infection":[8],"and":[9,26,42,56,92,126,192,209],"clinical":[10,284],"outcomes":[11,117],"in":[12,40,49,129,151,159,187,195,246,293,327,354,445,464,483,508,527,546,565,583,607,631,656,681,705,730,754,828,850,872,899],"a":[13,80,146,301,335,362,385,453,472,516,535,554,573,591,615,639,664,689,713,738,762,836,858,880,907],"cohort":[14],"MS":[16,38,91,249],"patients":[17,258],"who":[18],"were":[19,58,88,118,131,157,199],"treated":[20,248],"with":[21,69,90,133,214,237,519,538,557,840,862],"ocrelizumab":[22,70,94,247],"before":[23],"first,":[24],"second,":[25],"third":[27,165],"BNT162b2":[28,103],"mRNA":[29,104,244],"vaccinations.":[30,105],"Background:":[31],"The":[32,77,106,124,185,265,318,345,367,772,783,795,915],"study":[33,78,153,266],"included":[34],"participants":[35,130,169,179],"from":[36,110,376,384,781,792,804,812,820,924],"three":[37,102],"clinics":[39],"Denmark":[41],"University":[44],"California,":[46],"San":[47],"Francisco":[48],"United":[51],"States":[52],"when":[53],"omicron":[54],"BA.1":[55],"BA.2":[57],"dominating":[60],"subtypes":[61],"SARS-CoV-2.":[63],"Reduced":[64],"humoral":[65,125],"response":[66],"is":[67],"associated":[68],"treatment":[71,95],"multiple":[73],"sclerosis":[74],"(MS).":[75],"Design/Methods:":[76],"was":[79,109],"prospective":[81],"nonrandomized":[82],"controlled":[83],"observational":[84],"multicenter":[85],"trial.":[86],"Participants":[87],"diagnosed":[89],"received":[93,290,324,351,373,381,442,461,480,505,524,543,562,580,604,628,653,678,702,727,751,778,789,801,809,817,825,847,869,896,921],"for":[96,272,282,298,309,332,343,359,365,450,456,469,475,488,500,513,532,551,570,575,588,599,612,623,636,647,661,672,686,697,710,721,735,746,759,770,833,855,877,888,904,910],">12":[97],"months":[98],"prior":[99],"to":[100,113,176,269,280,316,388,395,401,407,413,419,425,431,437],"follow-up":[107],"period":[108],"January":[111],"2021":[112],"May":[114],"2022.":[115],"Clinical":[116],"evaluated":[119],"using":[120],"WHO":[121],"progression":[122],"scale.":[123],"cellular":[127],"immunogenicity":[128],"correlated":[132],"PCR":[134,149],"confirmed":[135],"infection.":[137,264],"Results:":[138],"Out":[139],"54":[141],"participants,":[142],"32":[143],"(59.3%)":[144],"developed":[145],"positive":[147],"test":[150],"period.":[154],"Mild":[155],"infections":[156],"observed":[158],"all":[160],"infected":[161,178],"participants.":[162,250],"After":[163],"vaccination,":[166],"non-infected":[168],"had":[170],"higher":[171],"mean":[172],"antibody":[173],"levels":[174,204],"compared":[175],"(54.3":[180],"vs.":[181],"26.5":[182],"BAU/mL,":[183],"p=0.030).":[184],"difference":[186],"reactivity":[188],"between":[189],"spike-specific":[190],"CD4+":[191],"CD8+":[193],"T-lymphocytes":[194],"two":[197],"groups":[198],"non-significant.":[200],"Additional":[201],"results":[202,229],"regarding":[203],"ocrelizumab,":[206],"anti-ocrelizumab":[207],"antibodies":[208],"nucleocapsid":[211],"protein,":[212],"together":[213],"immunological":[216],"effects":[217],"fourth":[219],"vaccination":[220,245,254],"will":[221],"be":[222],"presented":[223],"at":[224],"conference.":[226],"Conclusions:":[227],"Our":[228],"demonstrate":[230],"high":[231],"rates":[232],"infections,":[235],"along":[236],"mild":[238],"disease":[239],"courses":[240],"after":[241],"3rd":[242],"This":[251],"suggests":[252],"that":[253],"B-cell":[256],"depleted":[257],"provides":[259],"low":[260],"protection":[261],"against":[262],"findings":[267],"point":[268],"need":[271],"better":[273,283],"prophylactic":[274],"options":[275],"or":[276,304,338,495,594,618,642,667,692,716,741,765,883],"more":[277],"specific":[278],"vaccines":[279],"allow":[281],"protection.":[285],"Disclosure:":[286],"Dr.":[287,378,391,403,439,458,477,502,521,540,559,577,601,625,650,675,699,724,748,775,786,798,806,814,822,844],"Novak":[288],"has":[289,314,323,350,372,380,393,399,405,411,417,423,429,435,441,460,479,504,523,542,561,579,603,627,652,677,701,726,750,777,788,800,808,816,824,846,868,895,920],"personal":[291,325,352,443,462,481,506,525,544,563,581,605,629,654,679,703,728,752,826,848,870,897],"compensation":[292,326,353,444,463,482,507,526,545,564,582,606,630,655,680,704,729,753,827,849,871,898],"range":[295,329,356,447,466,485,510,529,548,567,585,609,633,658,683,707,732,756,830,852,874,901],"$500-$4,999":[297,331,358,449,468,487,512,531,550,587,734,758,832,854,876,903],"serving":[299,333,360,451,470,489,514,533,552,571,589,613,637,662,687,711,736,760,834,856,878,905],"on":[300,334,361,452,471,590,614,638,663,688,712,737,761,879,906],"Scientific":[302,336,592,616,640,665,690,714,739,763,881],"Advisory":[303,337,497,517,536,555,593,617,641,666,691,715,740,764,882],"Data":[305,339,595,619,643,668,693,717,742,766,884],"Safety":[306,340,596,620,644,669,694,718,743,767,885],"Monitoring":[307,341,597,621,645,670,695,719,744,768,886],"board":[308,342,598,622,646,671,696,720,745,769,887],"Sanofi":[310],"A/S.":[311],"Mr.":[312,415],"Bajwa":[313],"nothing":[315,394,400,406,412,418,424,430,436],"disclose.":[317,396,402,408,414,420,426,432,438],"institution":[319,346,368,773,784,796,916],"Prof.":[321,348,370,421],"Coia":[322,349,371],"Tillotts.":[344,366,377],"Speakers":[363,454,473,908],"Bureau":[364,455,474,909],"research":[374,779,790,802,810,818,922],"support":[375,780,791,803,811,819,923],"Nilsson":[379],"publishing":[382],"royalties":[383],"publication":[386],"relating":[387],"health":[389],"care.":[390],"Nielsen":[392],"Mrs.":[397],"Holm":[398],"Ostergaard":[404],"Miss":[409],"Hvidt":[410],"BYG":[416],"Johansen":[422],"Ms.":[427],"Mittl":[428],"William":[433],"Rowles":[434],"Zamvil":[440,459,478,503,522,541],"Alexion.":[457,558,771],"Genzyme.":[476,520],"as":[490,515,534,553,572,835,857],"an":[491],"Editor,":[492,494],"Associate":[493],"Editorial":[496],"Board":[498,518,537,556],"Member":[499],"AAN.":[501],"Genentech.":[539,794],"Bove":[560,578,602,626,651,676,700,725,749,776,787,799],"$5,000-$9,999":[569,611,635],"Consultant":[574],"Biogen.":[576,624,782],"Horizon.":[600],"EMD":[648],"Serono.":[649],"$10,000-$49,999":[660,685,709],"Genzyme":[673],"Sanofi.":[674],"Novartis.":[698,805,813],"TG":[722],"Therapeutics.":[723],"Jansen.":[747],"Roche":[793],"Sabatino":[807,815,823,845],"Roche/Genentech.":[821],"CME":[837,859],"course":[838,860],"instructor":[839,861],"eMultiple":[841],"Sclerosis":[842],"Review.":[843],"Physician":[863],"Education":[864],"Resource.":[865],"Tobias":[866,893,918],"Sejbaek":[867,894,919],"Biogen,":[889,911,925],"Merck,":[890,912,926],"Novartis,":[891,913,927],"Roche.":[892,928],"Teva.":[914]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-29T00:00:00"}